Literature DB >> 16206195

Osteosarcoma relapse: expect the worst, but hope for the best.

Pete Anderson1.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16206195     DOI： 10.1002/pbc.20615

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN： 1545-5009            Impact factor:   3.167


× No keyword cloud information.
  4 in total

Review 1.  Improving outcomes in difficult bone cancers using multimodality therapy, including radiation: physician and nursing perspectives.

Authors:  Pete Anderson; Maritza Salazar-Abshire
Journal:  Curr Oncol Rep       Date:  2006-11       Impact factor: 5.075

Review 2.  RANKL/RANK/OPG: key therapeutic target in bone oncology.

Authors:  Kosei Ando; Kanji Mori; Francoise Rédini; Dominique Heymann
Journal:  Curr Drug Discov Technol       Date:  2008-09

3.  Aerosol gemcitabine: preclinical safety and in vivo antitumor activity in osteosarcoma-bearing dogs.

Authors:  Carlos O Rodriguez; Torrie A Crabbs; Dennis W Wilson; Virginia A Cannan; Katherine A Skorupski; Nancy Gordon; Nadya Koshkina; Eugenie Kleinerman; Peter M Anderson
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2010-08       Impact factor: 2.849

4.  Arterial embolization in the management of connective tissue tumours.

Authors:  Oisin Jf Keenan; Buchir Arumilli; Finn Farquharson; Nicholas Chalmers; Ashok Paul
Journal:  JRSM Short Rep       Date:  2013-06-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.